Safety and efficacy of adalimumab for moderate to severe Crohn's disease in children.
Hyams JS, Griffiths A, Markowitz J, Baldassano RN, Faubion WA Jr, Colletti RB, Dubinsky M, Kierkus J, Rosh J, Wang Y, Huang B, Bittle B, Marshall M, Lazar A.
Hyams JS, et al. Among authors: faubion wa jr.
Gastroenterology. 2012 Aug;143(2):365-74.e2. doi: 10.1053/j.gastro.2012.04.046. Epub 2012 May 2.
Gastroenterology. 2012.
PMID: 22562021
Clinical Trial.